CGP 36742

CAT: 0804-HY-121599-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-121599-01Size:5 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CGP 36742 (SGS-742) is an orally active and selective antagonist of GABAB receptor (IC50 = 36 µM) . CGP 36742 is a blood-brain barrier (BBB) penetrant compound and improves cognitive performances. CGP 36742 can be used for depression study[1][2][3][4].
CAS Number
[123690-78-8]
Product Name Alternative
SGS-742
UNSPSC
12352211
Hazard Statement
H302, H319
Target
GABA Receptor
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cgp-36742.html
Purity
98.0
Solubility
H2O : 125 mg/mL (ultrasonic)
Smiles
O=P(CCCN)(O)CCCC
Molecular Formula
C7H18NO2P
Molecular Weight
179.20
Precautions
H302, H319
References & Citations
[1]Nowak G, et al. Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents. Br J Pharmacol. 2006 Nov;149 (5) :581-90.|[2]Olpe HR, et al. The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitro. Eur J Pharmacol. 1993 Mar 23;233 (2-3) :179-86.|[3]Andrén PE, et al. Blood-brain barrier penetration of 3-aminopropyl-n-butylphosphinic acid (CGP 36742) in rat brain by microdialysis/mass spectrometry. J Mass Spectrom. 1998 Mar;33 (3) :281-7. |[4]Pittaluga A, et al. Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABA (B) receptor antagonists. Neuropharmacology. 2001 Sep;41 (3) :301-10.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2

Popular Products